Citadel Advisors
PAVM icon

Citadel Advisors’s PAVmed PAVM Stock Holding History

Citadel Advisors’s Portfolio PAVM Stock Details PAVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3
Closed -$72 – 14393
2025
Q1 		$72 Buy
+3
New +$62 ﹤0.01% 14338
2023
Q3 		– Sell
-3
Closed -$489 – 14882
2023
Q2 		$489 Buy
+3
New +$600 ﹤0.01% 14101
2023
Q1 		– Sell
-27
Closed -$5.9K – 15288
2022
Q4 		$5.9K Sell
27
-14
-34% -$5.29K ﹤0.01% 13958
2022
Q3 		$16K Sell
41
-73
-64% -$41.4K ﹤0.01% 12147
2022
Q2 		$48K Sell
114
-84
-42% -$40.6K ﹤0.01% 11963
2022
Q1 		$117K Sell
198
-147
-43% -$109K ﹤0.01% 12112
2021
Q4 		$382K Buy
345
+56
+19% +$122K ﹤0.01% 10341
2021
Q3 		$1.11M Buy
289
+78
+37% +$246K ﹤0.01% 7875
2021
Q2 		$607K Buy
211
+61
+41% +$144K ﹤0.01% 9589
2021
Q1 		$299K Buy
+150
New +$226K ﹤0.01% 10862

Other funds holding PAVM

First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
OWP
Obermeyer Wealth Partners Aspen, Colorado $2.44B AUM 24.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Citadel Advisors's PAVM Position: Q1 2023 in Review

Citadel Advisors sold out of PAVmed (PAVM) in Q1 2023, closing a stake of 56 shares — an estimated $11.8K sold.

Citadel Advisors first reported a position in PAVM in Q2 2019 and held it in 11 quarters. The position peaked at $3.95M in Q4 2021. 58 funds tracked by Wall St. Rank hold PAVM as of Q1 2023.

  • Citadel Advisors reported no remaining PAVmed position as of Q1 2023 after selling out during the quarter.
  • Citadel Advisors sold 56 PAVmed shares in Q1 2023, an estimated $11.8K.
  • Citadel Advisors first reported a position in PAVmed in Q2 2019 and held it in 11 quarters.
  • Citadel Advisors's PAVmed position peaked at $3.95M in Q4 2021.
  • 58 funds tracked by Wall St. Rank held PAVmed as of Q1 2023.

Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.